推荐产品
用途
sufficient for 100 colorimetric or fluorometric tests
應用
pharmaceutical
檢測方法
colorimetric
fluorometric
運輸包裝
dry ice
儲存溫度
−20°C
一般說明
神经氨酸酶，也称为唾液酸酶，是一种水解多糖链上末端唾液酸残基的酶。它主要在细菌和病毒等微生物中表达。据信神经氨酸酶切割唾液酸残基在流感病毒感染中起多种作用。人们认为它有助于粘膜衬里的渗透、靶细胞的入侵、子代病毒从感染细胞中的洗脱以及防止自聚集。因此，神经氨酸酶是流感药物开发的重要目标，用于测量神经氨酸酶活性的简单，直接和自动化的程序在研究和药物发现中得到了广泛的应用。
應用
- 5-Nitrobenzo[c][1, 2, 5]selenadiazole as therapeutic agents in the regulation of oxidative stress and inflammation induced by influenza A(H1N1)pdm09 in vitro and in vivo.: This research utilized the Neuraminidase Activity Assay Kit to explore therapeutic agents that regulate oxidative stress and inflammation, showcasing its crucial role in antiviral research and potential pharmacological applications (Guo et al., 2023).
- Potency of bacterial sialidase Clostridium perfringens as antiviral of Newcastle disease infections using embryonated chicken egg in ovo model.: Highlights the kit′s use to measure and observe sialidase enzyme activity to assess the antiviral potential of bacterial enzymes against poultry diseases, contributing to the development of novel biocontrol methods (Kurnia et al., 2022).
- Molecular Docking Studies and Biological Evaluation of Berberine-Benzothiazole Derivatives as an Anti-Influenza Agent via Blocking of Neuraminidase.: Utilizes neuraminidase assay kit to evaluate the efficacy of synthesized compound′s neuraminidase activity, offering a path towards the design of new antiviral drugs with enhanced specificity and potency (Kumar et al., 2021).
特點和優勢
兼容高通量的操作系统。
適合性
适用于生物样品中的神经氨酸酶活性检测，可用于筛选神经氨酸酶抑制剂。
原則
在该测定中，神经氨酸酶活性通过酶促测定法测定，其中神经氨酸酶释放的唾液酸产生与样品中神经氨酸酶活性成正比的比色（570 nm）/荧光（λex = 530/λem = 585 nm）产物。在37°C下的线性检测范围对于比色测定为0.1-10单位/L，对于荧光测定为0.01-2单位/L。
訊號詞
Danger
危險聲明
危險分類
Resp. Sens. 1 - Skin Sens. 1
儲存類別代碼
10 - Combustible liquids
其他客户在看
Irene Gómez Delgado et al.
Frontiers in immunology, 12, 641656-641656 (2021-03-30)
Haemolytic Uraemic Syndrome associated with Streptococcus pneumoniae infections (SP-HUS) is a clinically well-known entity that generally affects infants, and could have a worse prognosis than HUS associated to E. coli infections. It has been assumed that complement genetic variants associated
Aurora Salamanca et al.
Antiviral chemistry & chemotherapy, 29, 20402066211063391-20402066211063391 (2021-11-30)
Seasonal flu is caused by influenza infection, a virus that spreads easily in human population with periodical epidemic outbreaks. The high mutational rate of influenza viruses leads to the emergence of strains resistant to the current treatments. Due to that
Rose T Byrne-Nash et al.
NPJ vaccines, 4, 3-3 (2019-01-25)
Neuraminidase (NA) immunity leads to decreased viral shedding and reduced severity of influenza disease; however, NA content in influenza vaccines is currently not regulated, resulting in inconsistent quality and quantity of NA that can vary from manufacturer to manufacturer, from
Alfred T Harding et al.
mBio, 8(3) (2017-06-08)
Influenza virus vaccine production is currently limited by the ability to grow circulating human strains in chicken eggs or in cell culture. To facilitate cost-effective growth, vaccine strains are serially passaged under production conditions, which frequently results in mutations of
Ryan Septa Kurnia et al.
Journal of advanced veterinary and animal research, 9(2), 335-345 (2022-07-28)
The Newcastle disease virus (NDV) is an infectious disease that causes very high economic losses due to decreased livestock production and poultry deaths. The vaccine's ineffectiveness due to mutation of the genetic structure of the virus impacts obstacles in controlling
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门